BMY
Bristol Myers Squibb insider trading
Health Care · Heavy selling
Close · Oct 5, 2026
$58.81
+36.1% over 12 months
Share price and insider trades
BMY closeInsider buyInsider sale
Bought, 12 months$0
Sold, 12 months$2.3M
Insiders buying0
Insiders selling3
Valuation, profit and volume
P/E (trailing)n/aSector median 24.5
Market value—
Profit margin—Revenue growth —
Volume vs. 50-day1.3×Last 5 sessions
Insiders' paper profit—On all tracked purchases —
Summary
Over the past 12 months, 0 Bristol Myers Squibb insiders reported open-market purchases totaling $0, while 3 insiders reported sales totaling $2.3M. 2 of 4 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales. 134 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 10SEC | Cristian MassacesiEvp,Chief Med Offr,Head Of Dev | Sell | 6,249 | $64.57 | $403K | -8.9% | — |
| Aug 26SEC | Phil M HolzerSvp And Controller | Sell | 500 | $67.50 | $34K | -12.9% | — |
| Apr 2SEC | David V ElkinsCFO | Sell Plan | 25,519 | $61.60 | $1.6M | -4.5% | — |
| Apr 2SEC | David V ElkinsCFO | Sell Plan | 4,481 | $62.05 | $278K | -5.2% | — |
Insiders at Bristol Myers Squibb
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| David V ElkinsCFO | — | $1.9M | Apr 2, 2026 | — |
| Cristian MassacesiEvp,Chief Med Offr,Head Of Dev | — | $403K | Sep 10, 2026 | — |
| Phil M HolzerSvp And Controller | — | $34K | Aug 26, 2026 | — |
| Bartie Wendy ShortEvp, Corporate Affairs | — | — | Sep 3, 2026 | — |
| Cari GallmanGeneral Counsel | — | — | Aug 4, 2026 | — |
| Julia A HallerDirector | — | — | Jun 16, 2026 | — |
| Adam LenkowskyEvp, Chief Commercial Officer | — | — | May 5, 2026 | — |
| Karin ShanahanEvp, Chief Supply Chain & Ops | — | — | Apr 2, 2026 | — |
| Christopher S. BoernerCEO | — | — | Mar 12, 2026 | — |
| Gregory Scott MeyersEvp, Chief Digital & Tech Off. | — | — | Mar 12, 2026 | — |
| Robert M PlengeEvp, Chief Research Officer | — | — | Mar 12, 2026 | — |
| Ahn Amanda PooleEvp, Chief People Officer | — | — | Mar 12, 2026 | — |
| Lynelle HochPresident | — | — | Mar 12, 2026 | — |
| Benjamin HickeyPresident | — | — | Mar 3, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
Common questions about BMY insiders
Are Bristol Myers Squibb insiders buying BMY stock?
In the past 12 months, 0 insiders reported open-market purchases of BMY worth $0.
Are Bristol Myers Squibb insiders selling BMY stock?
3 insiders reported sales worth $2.3M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.